BerGenBio ASA (0RU5.L)

NOK 9.0

(-0.03%)

Total Assets Summary of BerGenBio ASA

BerGenBio ASA's latest annual total assets in 2023 was 174.33 Million NOK , up 4.58% from previous year.
BerGenBio ASA's latest quarterly total assets in 2024 Q2 was 218.47 Million NOK , up 61.31% from previous quarter.
BerGenBio ASA reported annual total assets of 166.7 Million NOK in 2022, down -62.97% from previous year.
BerGenBio ASA reported annual total assets of 450.23 Million NOK in 2021, down -39.01% from previous year.
BerGenBio ASA reported quarterly total assets of 135.43 Million NOK for 2024 Q1, down -22.31% from previous quarter.
BerGenBio ASA reported quarterly total assets of 240.44 Million NOK for 2023 Q2, up 180.84% from previous quarter.

Annual Total Assets Chart of BerGenBio ASA (2023 - 2014)

Historical Annual Total Assets of BerGenBio ASA (2023 - 2014)

Year	Total Assets	Total Assets Growth
2023	174.33 Million NOK	4.58%
2022	166.7 Million NOK	-62.97%
2021	450.23 Million NOK	-39.01%
2020	738.2 Million NOK	173.03%
2019	270.37 Million NOK	-28.63%
2018	378.82 Million NOK	-1.43%
2017	384.33 Million NOK	120.2%
2016	174.53 Million NOK	111.84%
2015	82.39 Million NOK	-32.25%
2014	121.6 Million NOK	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	218.47 Million NOK	61.31%
2024 Q1	135.43 Million NOK	-22.31%
2023 Q2	240.44 Million NOK	180.84%
2023 Q1	85.61 Million NOK	-48.64%
2023 FY	174.33 Million NOK	4.58%
2023 Q4	174.33 Million NOK	-7.27%
2023 Q3	187.99 Million NOK	-21.81%
2022 Q1	380.6 Million NOK	-15.47%
2022 Q4	166.7 Million NOK	-29.22%
2022 FY	166.7 Million NOK	-62.97%
2022 Q3	235.51 Million NOK	-23.04%
2022 Q2	306.03 Million NOK	-19.59%
2021 Q4	450.23 Million NOK	-12.57%
2021 FY	450.23 Million NOK	-39.01%
2021 Q2	584.77 Million NOK	-13.14%
2021 Q3	514.99 Million NOK	-11.93%
2021 Q1	673.21 Million NOK	-8.8%
2020 Q2	844.4 Million NOK	94.66%
2020 FY	738.2 Million NOK	173.03%
2020 Q1	433.77 Million NOK	60.43%
2020 Q3	795.21 Million NOK	-5.83%
2020 Q4	738.2 Million NOK	-7.17%
2019 Q3	310.19 Million NOK	-11.12%
2019 Q2	349 Million NOK	3.83%
2019 Q1	336.13 Million NOK	-11.27%
2019 FY	270.37 Million NOK	-28.63%
2019 Q4	270.37 Million NOK	-12.84%
2018 Q1	341.61 Million NOK	-11.12%
2018 FY	378.82 Million NOK	-1.43%
2018 Q4	378.82 Million NOK	-9.91%
2018 Q3	420.49 Million NOK	-7.77%
2018 Q2	455.91 Million NOK	33.46%
2017 Q4	384.33 Million NOK	-8.06%
2017 FY	384.33 Million NOK	120.2%
2017 Q2	457.31 Million NOK	0.0%
2017 Q3	418.03 Million NOK	-8.59%
2016 Q4	174.53 Million NOK	0.0%
2016 FY	174.53 Million NOK	111.84%
2015 FY	82.39 Million NOK	-32.25%
2014 FY	121.6 Million NOK	0.0%

Peer Total Assets Comparison of BerGenBio ASA

Name	Total Assets	Total Assets Difference
Photocure ASA	711.26 Million NOK	75.489%